Showing results (91-100 of 130) with videos related to
Sort By:
Pageof 13
Plos One|October 27, 2017
Body mass index influences infliximab post-infusion levels and correlates with prospective loss of response to the drug in a cohort of inflammatory bowel disease patients under maintenance therapy with InfliximabFranco Scaldaferri, Daria D'Ambrosio, Grainne Holleran, et al.Journal of Crohn'S & Colitis|April 29, 2017
Training Programs on Endoscopic Scoring Systems for Inflammatory Bowel Disease Lead to a Significant Increase in Interobserver Agreement Among Community GastroenterologistsMarco Daperno, Michele Comberlato, Fabrizio Bossa, et al.Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|November 26, 2022
Radiomics could predict surgery at 10 years in Crohn's diseaseLucrezia Laterza, Luca Boldrini, Huong Elena Tran, et al.Journal of Personalized Medicine|May 25, 2024
Histologic Disease Persists beyond Mucosal Healing and Could Predict Reactivation in Ulcerative ColitisLucrezia Laterza, Anna Chiara Piscaglia, Stefano Bibbò, et al.Journal of Gastrointestinal and Liver Diseases : JGLD|December 26, 2023
Effectiveness and Safety of Switching from Intravenous to Subcutaneous Vedolizumab Formulation in Inflammatory Bowel Disease Patients in Clinical RemissionLaura Parisio, Carlo Romano Settanni, Simone Varca, et al.Inflammatory Bowel Diseases|July 8, 2026
Timing of biologic prophylaxis and postoperative recurrence in Crohn's disease: A real-life cohort study using propensity score weightingAngelo Del Gaudio, Federica Di Vincenzo, Giuseppe Cuccia, et al.Indian Journal of Gastroenterology : Official Journal of the Indian Society of Gastroenterology|January 20, 2024
Transition from intravenous to subcutaneous biological therapies in inflammatory bowel disease: An online survey of patientsDaniele Napolitano, Carlo Romano Settanni, Laura Parisio, et al.Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|May 30, 2026
Vedolizumab for the prevention and treatment of postoperative recurrence in Crohn's disease: A real- world latium net studyAngelo Del Gaudio, Emma Calabrese, Paola Balestrieri, et al.Inflammatory Bowel Diseases|April 28, 2026
OCTN1 variants shape innate immunity and predict individual response to anti-TNFα in ulcerative colitis patients: An exploratory studyPierluigi Puca, Letizia Masi, Simone Parello, et al.Journal of Crohn'S & Colitis|December 29, 2025
Inflammatory Bowel Disease is associated with increased intestinal extrachromosomal circular DNA: an emerging biomarker for IBD type and activityValentina Petito, Daniela Gerovska, Antonia Piazzesi, et al.Pageof 13